King Luther Capital Management Corp Vertex Pharmaceuticals Inc Transaction History

King Luther Capital Management Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	SELL	$314.42 - $351.91 $214,434 - $240,002	-682 Reduced 54.39%	572 $201,000
Q1 2023 May 11, 2023	BUY	$283.23 - $323.1 $1,699 - $1,938	6 Added 0.48%	1,254 $395,000
Q4 2022 Feb 13, 2023	BUY	$285.76 - $321.48 $8,858 - $9,965	31 Added 2.55%	1,248 $360,000
Q3 2022 Nov 10, 2022	BUY	$273.83 - $305.53 $73,934 - $82,493	270 Added 28.51%	1,217 $352,000
Q2 2022 Aug 11, 2022	BUY	$234.96 - $292.55 $222,507 - $277,044	947 New	947 $267,000

1,724

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of King Luther Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on King Luther Capital Management Corp with notifications on news.